换一批
换一批A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
作者：
Aglietta,M. [1]
;
Barone,C. [2]
;
Sawyer,M.B. [3]
;
Moore,M.J. [4]
;
MillerJr.,W.H. [5]
;
Bagalà,C. [6]
;
Colombi,F. ;
Cagnazzo,C. ;
Gioeni,L. ;
Wang,E. ;
Huang,B. ;
Fly,K.D. ;
Leone,F.
作者单位：
Pfizer Oncology Global Research and Development, Groton, CT, United States
[1]
Division of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, ON
[2]
Department of Medical Oncology, University of Torino, Candiolo Cancer Institute-FPO, IRCCS, Turin
[3]
Department of Oncology, University of Alberta, Edmonton, AB, Canada
[4]
Department of Oncology, McGill University, Montreal, QC, Canada
[5]
Department of Medical Oncology, Catholic University of the Sacred Heart, Rome, Italy
[6]
期刊：
发布时间：
2014-12-11
- 翻译满意度评价：
- 提交
- 浏览：4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
